Jessica Tassan Analyst Performance

Sr. Research Analyst at Piper Sandler

Jessica Tassan is a stock analyst at Piper Sandler focused in the medical sector, covering 16 publicly traded companies. Over the past year, Jessica Tassan has issued 22 stock ratings, including buy and hold recommendations. While full access to Jessica Tassan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jessica Tassan's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 27 Last 3 Years
Buy Recommendations: 61.54% 16 Buy Ratings
Companies Covered: 16 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	61.5%	16 ratings
Hold	34.6%	9 ratings
Sell	3.8%	1 ratings

Out of 26 total stock ratings issued by Jessica Tassan at Piper Sandler, the majority (61.5%) have been Buy recommendations, followed by 34.6% Hold and 3.8% Sell.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NYSE	68.8% of companies on NYSE	11 companies
NASDAQ	31.3% of companies on NASDAQ	5 companies

Jessica Tassan, an analyst at Piper Sandler, currently covers 16 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 14 companies	87.5%
	Computer and Technology 1 company	6.3%
	Finance 1 company	6.3%

Jessica Tassan of Piper Sandler specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Finance companies.

Coverage Industries

Industry	Percentage
MEDICAL INFO SYS 4 companies	25.0%
MEDICAL SERVICES 4 companies	25.0%
MED - HMO 3 companies	18.8%
INTERNET SOFTWARE 1 company	6.3%
INS - MULTI LINE 1 company	6.3%
CUSTOM COMPUTER PROGRAMMING SERVICES 1 company	6.3%
DATA PROCESSING & PREPARATION 1 company	6.3%
OFFICES & CLINICS OF MEDICAL DOCTORS 1 company	6.3%

About Jessica Tassan

Jessica Tassan is a vice president and senior research analyst at Piper Sandler with primary coverage of the healthcare IT & delivery sector. She joined Piper Sandler in 2016 as an equity sales associate covering the San Francisco market, with a focus on healthcare investors. Prior to Piper, Tassan spent time at UBS in San Francisco and New York. She graduated from the University of Connecticut, where she worked as an analyst at the Connecticut Center for Economic Analysis and earned bachelor's degrees in economics and political science. Tassan is based in San Francisco, where she keeps a finger on the pulse of trends in healthcare transformation and innovation.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
PHR Phreesia	9/5/2025	Boost Price Target	$31.31	$34.00	Overweight
EVH Evolent Health	8/28/2025	Boost Price Target	$9.65	$18.00	Overweight
HCAT Health Catalyst	8/27/2025	Downgrade	$3.50	$4.00	Neutral
PINC Premier	8/25/2025	Boost Price Target	$25.50	$28.00	Neutral
OSCR Oscar Health	8/14/2025	Lower Price Target	$14.61	$13.00	Neutral
DOCS Doximity	8/11/2025	Boost Price Target	$66.71	$69.00	Overweight
HUM Humana	7/31/2025	Lower Price Target	$255.66	$272.00	Neutral
UNH UnitedHealth Group	7/30/2025	Lower Price Target	$260.86	$317.00	Overweight
HNGE Hinge Health	6/16/2025	Initiated Coverage	$34.76	$41.00	Overweight
OSCR Oscar Health	6/9/2025	Lower Price Target	$15.41	$18.00	Overweight
UNH UnitedHealth Group	6/3/2025	Lower Price Target	$302.22	$353.00	Overweight
AMWL American Well	5/23/2025	Reiterated Rating	$7.23	$8.00	Neutral
PINC Premier	5/21/2025	Boost Price Target	$23.34	$24.00	Neutral
CI Cigna Group	5/5/2025	Boost Price Target	$333.66	$374.00	Overweight
CVS CVS Health	3/21/2025	Boost Price Target	$68.71	$74.00	Overweight
ALHC Alignment Healthcare	3/4/2025	Boost Price Target	$15.44	$21.00	Overweight
TDOC Teladoc Health	2/27/2025	Lower Price Target	$10.91	$12.00	Overweight
EVH Evolent Health	2/21/2025	Reiterated Rating	$10.60	$16.00	Overweight
HCAT Health Catalyst	2/11/2025	Lower Price Target	$5.75	$8.00	Overweight
PINC Premier	2/5/2025	Lower Price Target	$19.12	$19.00	Neutral
CI Cigna Group	2/3/2025	Reiterated Rating	$294.59	$348.00	Overweight
PHR Phreesia	1/29/2025	Reiterated Rating	$29.59	$33.00	Overweight

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.